Search research articles
Contact Us
Filters
Showing results (21-30 of 119) with videos related to
Page
of 12
Sort By:
Expert Review of Proteomics
|
October 9, 2009
Urinary proteomic profiling for diagnostic bladder cancer biomarkers
Steve Goodison, Charles J Rosser, Virginia Urquidi
Oncoscience
|
May 20, 2020
Computational disease progression modeling can provide insights into cancer evolution
Steve Goodison, Mark E Sherman, Yijun Sun
Scientific Reports
|
July 8, 2017
Prognostic cancer gene signatures share common regulatory motifs
Ying Wang, Steve Goodison, Xiaoman Li, et al.
Briefings in Bioinformatics
|
December 31, 2024
A comprehensive benchmark study of methods for identifying significantly perturbed subnetworks in cancer
Le Yang, Runpu Chen, Steve Goodison, et al.
BMC Genomics
|
September 25, 2003
The interrelationship between DRIM gene expression and cytogenetic and phenotypic characteristics in human breast tumor cell lines
Steve Goodison, Carrie Viars, Maren Grazzini, et al.
Bioinformatics (Oxford, England)
|
October 12, 2019
Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data
Runpu Chen, Le Yang, Steve Goodison, et al.
Nature Computational Science
|
June 22, 2023
An efficient and effective method to identify significantly perturbed subnetworks in cancer
Le Yang, Runpu Chen, Steve Goodison, et al.
Proteomics
|
September 8, 2004
Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique
Paweena Kreunin, Virginia Urquidi, David M Lubman, et al.
Genome Biology
|
August 27, 2014
Cancer progression modeling using static sample data
Yijun Sun, Jin Yao, Norma J Nowak, et al.
Biomarkers in Medicine
|
February 18, 2010
Urine-based assays for the detection of bladder cancer
Patrick Villicana, Bryant Whiting, Steve Goodison, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 119) with videos related to
Sort By:
Page
of 12
Expert Review of Proteomics
|
October 9, 2009
Urinary proteomic profiling for diagnostic bladder cancer biomarkers
Steve Goodison, Charles J Rosser, Virginia Urquidi
Oncoscience
|
May 20, 2020
Computational disease progression modeling can provide insights into cancer evolution
Steve Goodison, Mark E Sherman, Yijun Sun
Scientific Reports
|
July 8, 2017
Prognostic cancer gene signatures share common regulatory motifs
Ying Wang, Steve Goodison, Xiaoman Li, et al.
Briefings in Bioinformatics
|
December 31, 2024
A comprehensive benchmark study of methods for identifying significantly perturbed subnetworks in cancer
Le Yang, Runpu Chen, Steve Goodison, et al.
BMC Genomics
|
September 25, 2003
The interrelationship between DRIM gene expression and cytogenetic and phenotypic characteristics in human breast tumor cell lines
Steve Goodison, Carrie Viars, Maren Grazzini, et al.
Bioinformatics (Oxford, England)
|
October 12, 2019
Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data
Runpu Chen, Le Yang, Steve Goodison, et al.
Nature Computational Science
|
June 22, 2023
An efficient and effective method to identify significantly perturbed subnetworks in cancer
Le Yang, Runpu Chen, Steve Goodison, et al.
Proteomics
|
September 8, 2004
Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique
Paweena Kreunin, Virginia Urquidi, David M Lubman, et al.
Genome Biology
|
August 27, 2014
Cancer progression modeling using static sample data
Yijun Sun, Jin Yao, Norma J Nowak, et al.
Biomarkers in Medicine
|
February 18, 2010
Urine-based assays for the detection of bladder cancer
Patrick Villicana, Bryant Whiting, Steve Goodison, et al.
Page
of 12